nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—ABCG2—Sulfasalazine—Crohn's disease	0.392	0.684	CbGbCtD
Topotecan—ABCB1—Prednisone—Crohn's disease	0.113	0.197	CbGbCtD
Topotecan—CYP3A4—Prednisone—Crohn's disease	0.0677	0.118	CbGbCtD
Topotecan—Myelosuppression—Mercaptopurine—Crohn's disease	0.0167	0.0397	CcSEcCtD
Topotecan—Acute leukaemia—Azathioprine—Crohn's disease	0.0164	0.0388	CcSEcCtD
Topotecan—Myelosuppression—Azathioprine—Crohn's disease	0.00997	0.0237	CcSEcCtD
Topotecan—Neoplasm—Mercaptopurine—Crohn's disease	0.00709	0.0168	CcSEcCtD
Topotecan—Sepsis—Mercaptopurine—Crohn's disease	0.00681	0.0162	CcSEcCtD
Topotecan—Interstitial lung disease—Azathioprine—Crohn's disease	0.00661	0.0157	CcSEcCtD
Topotecan—Intestinal obstruction—Mesalazine—Crohn's disease	0.00625	0.0148	CcSEcCtD
Topotecan—Lung disorder—Mesalazine—Crohn's disease	0.00602	0.0143	CcSEcCtD
Topotecan—Interstitial lung disease—Mesalazine—Crohn's disease	0.00602	0.0143	CcSEcCtD
Topotecan—Irinotecan—ALB—Crohn's disease	0.00589	1	CrCbGaD
Topotecan—Rigors—Azathioprine—Crohn's disease	0.00573	0.0136	CcSEcCtD
Topotecan—Pleural effusion—Mesalazine—Crohn's disease	0.00556	0.0132	CcSEcCtD
Topotecan—Rash erythematous—Mesalazine—Crohn's disease	0.00556	0.0132	CcSEcCtD
Topotecan—Dysmenorrhoea—Mesalazine—Crohn's disease	0.00468	0.0111	CcSEcCtD
Topotecan—Pancytopenia—Mercaptopurine—Crohn's disease	0.00468	0.0111	CcSEcCtD
Topotecan—Blood bilirubin increased—Mesalazine—Crohn's disease	0.0045	0.0107	CcSEcCtD
Topotecan—Colitis—Azathioprine—Crohn's disease	0.00449	0.0107	CcSEcCtD
Topotecan—Stomatitis—Mercaptopurine—Crohn's disease	0.00428	0.0102	CcSEcCtD
Topotecan—Neoplasm—Azathioprine—Crohn's disease	0.00423	0.01	CcSEcCtD
Topotecan—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00415	0.00985	CcSEcCtD
Topotecan—Colitis—Mesalazine—Crohn's disease	0.00409	0.00971	CcSEcCtD
Topotecan—Neuropathy—Mesalazine—Crohn's disease	0.004	0.00949	CcSEcCtD
Topotecan—Febrile neutropenia—Prednisone—Crohn's disease	0.00375	0.00889	CcSEcCtD
Topotecan—Ear pain—Mesalazine—Crohn's disease	0.00362	0.0086	CcSEcCtD
Topotecan—Immune system disorder—Mercaptopurine—Crohn's disease	0.00356	0.00845	CcSEcCtD
Topotecan—Alopecia—Mercaptopurine—Crohn's disease	0.00348	0.00826	CcSEcCtD
Topotecan—Malnutrition—Mercaptopurine—Crohn's disease	0.00343	0.00814	CcSEcCtD
Topotecan—Dermatitis bullous—Mesalazine—Crohn's disease	0.00323	0.00768	CcSEcCtD
Topotecan—Anaemia—Mercaptopurine—Crohn's disease	0.00317	0.00753	CcSEcCtD
Topotecan—Lethargy—Mesalazine—Crohn's disease	0.00315	0.00749	CcSEcCtD
Topotecan—Leukopenia—Mercaptopurine—Crohn's disease	0.00307	0.00729	CcSEcCtD
Topotecan—Arthralgia—Mercaptopurine—Crohn's disease	0.00292	0.00693	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0029	0.00688	CcSEcCtD
Topotecan—Pancytopenia—Azathioprine—Crohn's disease	0.00279	0.00661	CcSEcCtD
Topotecan—Cramp muscle—Mesalazine—Crohn's disease	0.00278	0.00661	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00278	0.00661	CcSEcCtD
Topotecan—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00274	0.00651	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00273	0.00647	CcSEcCtD
Topotecan—Skin disorder—Mercaptopurine—Crohn's disease	0.00272	0.00645	CcSEcCtD
Topotecan—Anorexia—Mercaptopurine—Crohn's disease	0.00267	0.00633	CcSEcCtD
Topotecan—Pneumonia—Azathioprine—Crohn's disease	0.00263	0.00624	CcSEcCtD
Topotecan—Infestation NOS—Azathioprine—Crohn's disease	0.00262	0.00621	CcSEcCtD
Topotecan—Infestation—Azathioprine—Crohn's disease	0.00262	0.00621	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00255	0.00605	CcSEcCtD
Topotecan—Pancytopenia—Mesalazine—Crohn's disease	0.00254	0.00602	CcSEcCtD
Topotecan—Neutropenia—Mesalazine—Crohn's disease	0.0025	0.00593	CcSEcCtD
Topotecan—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00247	0.00587	CcSEcCtD
Topotecan—Decreased appetite—Mercaptopurine—Crohn's disease	0.00243	0.00578	CcSEcCtD
Topotecan—Weight increased—Mesalazine—Crohn's disease	0.00243	0.00577	CcSEcCtD
Topotecan—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00242	0.00574	CcSEcCtD
Topotecan—Pneumonia—Mesalazine—Crohn's disease	0.0024	0.00569	CcSEcCtD
Topotecan—Infestation NOS—Mesalazine—Crohn's disease	0.00238	0.00565	CcSEcCtD
Topotecan—Infestation—Mesalazine—Crohn's disease	0.00238	0.00565	CcSEcCtD
Topotecan—Haemoglobin—Azathioprine—Crohn's disease	0.00236	0.0056	CcSEcCtD
Topotecan—Haemorrhage—Azathioprine—Crohn's disease	0.00235	0.00557	CcSEcCtD
Topotecan—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00234	0.00554	CcSEcCtD
Topotecan—Stomatitis—Mesalazine—Crohn's disease	0.00232	0.00551	CcSEcCtD
Topotecan—Sweating—Mesalazine—Crohn's disease	0.00228	0.00542	CcSEcCtD
Topotecan—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00225	0.00535	CcSEcCtD
Topotecan—Epistaxis—Mesalazine—Crohn's disease	0.00225	0.00533	CcSEcCtD
Topotecan—Body temperature increased—Mercaptopurine—Crohn's disease	0.00221	0.00525	CcSEcCtD
Topotecan—Haemoglobin—Mesalazine—Crohn's disease	0.00215	0.0051	CcSEcCtD
Topotecan—Rhinitis—Mesalazine—Crohn's disease	0.00214	0.00509	CcSEcCtD
Topotecan—Haemorrhage—Mesalazine—Crohn's disease	0.00214	0.00508	CcSEcCtD
Topotecan—Pharyngitis—Mesalazine—Crohn's disease	0.00212	0.00504	CcSEcCtD
Topotecan—Immune system disorder—Azathioprine—Crohn's disease	0.00212	0.00503	CcSEcCtD
Topotecan—Mediastinal disorder—Azathioprine—Crohn's disease	0.00212	0.00502	CcSEcCtD
Topotecan—Neuropathy—Prednisone—Crohn's disease	0.00212	0.00502	CcSEcCtD
Topotecan—Chills—Azathioprine—Crohn's disease	0.00211	0.005	CcSEcCtD
Topotecan—Alopecia—Azathioprine—Crohn's disease	0.00207	0.00492	CcSEcCtD
Topotecan—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00206	0.0049	CcSEcCtD
Topotecan—Sepsis—Prednisone—Crohn's disease	0.00196	0.00464	CcSEcCtD
Topotecan—Angiopathy—Mesalazine—Crohn's disease	0.00194	0.00461	CcSEcCtD
Topotecan—Immune system disorder—Mesalazine—Crohn's disease	0.00193	0.00459	CcSEcCtD
Topotecan—Mediastinal disorder—Mesalazine—Crohn's disease	0.00193	0.00457	CcSEcCtD
Topotecan—Chills—Mesalazine—Crohn's disease	0.00192	0.00455	CcSEcCtD
Topotecan—Diarrhoea—Mercaptopurine—Crohn's disease	0.00192	0.00455	CcSEcCtD
Topotecan—Ill-defined disorder—Azathioprine—Crohn's disease	0.0019	0.0045	CcSEcCtD
Topotecan—Alopecia—Mesalazine—Crohn's disease	0.00189	0.00449	CcSEcCtD
Topotecan—Anaemia—Azathioprine—Crohn's disease	0.00189	0.00448	CcSEcCtD
Topotecan—Malaise—Azathioprine—Crohn's disease	0.00184	0.00437	CcSEcCtD
Topotecan—Leukopenia—Azathioprine—Crohn's disease	0.00183	0.00434	CcSEcCtD
Topotecan—Back pain—Mesalazine—Crohn's disease	0.0018	0.00427	CcSEcCtD
Topotecan—Muscle spasms—Mesalazine—Crohn's disease	0.00179	0.00425	CcSEcCtD
Topotecan—Vomiting—Mercaptopurine—Crohn's disease	0.00178	0.00422	CcSEcCtD
Topotecan—Rash—Mercaptopurine—Crohn's disease	0.00177	0.00419	CcSEcCtD
Topotecan—Dermatitis—Mercaptopurine—Crohn's disease	0.00176	0.00419	CcSEcCtD
Topotecan—Myalgia—Azathioprine—Crohn's disease	0.00174	0.00413	CcSEcCtD
Topotecan—Arthralgia—Azathioprine—Crohn's disease	0.00174	0.00413	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00173	0.0041	CcSEcCtD
Topotecan—Ill-defined disorder—Mesalazine—Crohn's disease	0.00173	0.0041	CcSEcCtD
Topotecan—Anaemia—Mesalazine—Crohn's disease	0.00172	0.00408	CcSEcCtD
Topotecan—Discomfort—Azathioprine—Crohn's disease	0.00172	0.00408	CcSEcCtD
Topotecan—Angioedema—Mesalazine—Crohn's disease	0.0017	0.00404	CcSEcCtD
Topotecan—Malaise—Mesalazine—Crohn's disease	0.00168	0.00398	CcSEcCtD
Topotecan—Lethargy—Prednisone—Crohn's disease	0.00167	0.00396	CcSEcCtD
Topotecan—Leukopenia—Mesalazine—Crohn's disease	0.00167	0.00396	CcSEcCtD
Topotecan—Nausea—Mercaptopurine—Crohn's disease	0.00166	0.00395	CcSEcCtD
Topotecan—Infection—Azathioprine—Crohn's disease	0.00166	0.00393	CcSEcCtD
Topotecan—Thrombocytopenia—Azathioprine—Crohn's disease	0.00163	0.00388	CcSEcCtD
Topotecan—Cough—Mesalazine—Crohn's disease	0.00162	0.00386	CcSEcCtD
Topotecan—Skin disorder—Azathioprine—Crohn's disease	0.00162	0.00385	CcSEcCtD
Topotecan—Arthralgia—Mesalazine—Crohn's disease	0.00158	0.00376	CcSEcCtD
Topotecan—Chest pain—Mesalazine—Crohn's disease	0.00158	0.00376	CcSEcCtD
Topotecan—Myalgia—Mesalazine—Crohn's disease	0.00158	0.00376	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00157	0.00374	CcSEcCtD
Topotecan—Discomfort—Mesalazine—Crohn's disease	0.00157	0.00372	CcSEcCtD
Topotecan—Cardiac arrest—Prednisone—Crohn's disease	0.00156	0.00369	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00152	0.00361	CcSEcCtD
Topotecan—Anaphylactic shock—Mesalazine—Crohn's disease	0.00152	0.00361	CcSEcCtD
Topotecan—Infection—Mesalazine—Crohn's disease	0.00151	0.00358	CcSEcCtD
Topotecan—Nervous system disorder—Mesalazine—Crohn's disease	0.00149	0.00354	CcSEcCtD
Topotecan—Thrombocytopenia—Mesalazine—Crohn's disease	0.00149	0.00353	CcSEcCtD
Topotecan—Skin disorder—Mesalazine—Crohn's disease	0.00148	0.0035	CcSEcCtD
Topotecan—Hyperhidrosis—Mesalazine—Crohn's disease	0.00147	0.00349	CcSEcCtD
Topotecan—Anorexia—Mesalazine—Crohn's disease	0.00145	0.00344	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00144	0.00342	CcSEcCtD
Topotecan—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00144	0.00342	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00138	0.00329	CcSEcCtD
Topotecan—Feeling abnormal—Azathioprine—Crohn's disease	0.00137	0.00326	CcSEcCtD
Topotecan—Paraesthesia—Mesalazine—Crohn's disease	0.00136	0.00324	CcSEcCtD
Topotecan—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00136	0.00324	CcSEcCtD
Topotecan—Dyspnoea—Mesalazine—Crohn's disease	0.00135	0.00322	CcSEcCtD
Topotecan—Dyspepsia—Mesalazine—Crohn's disease	0.00134	0.00317	CcSEcCtD
Topotecan—Neutropenia—Prednisone—Crohn's disease	0.00132	0.00314	CcSEcCtD
Topotecan—Decreased appetite—Mesalazine—Crohn's disease	0.00132	0.00314	CcSEcCtD
Topotecan—Abdominal pain—Azathioprine—Crohn's disease	0.00132	0.00313	CcSEcCtD
Topotecan—Body temperature increased—Azathioprine—Crohn's disease	0.00132	0.00313	CcSEcCtD
Topotecan—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00131	0.00311	CcSEcCtD
Topotecan—Fatigue—Mesalazine—Crohn's disease	0.00131	0.00311	CcSEcCtD
Topotecan—Constipation—Mesalazine—Crohn's disease	0.0013	0.00308	CcSEcCtD
Topotecan—Pain—Mesalazine—Crohn's disease	0.0013	0.00308	CcSEcCtD
Topotecan—Weight increased—Prednisone—Crohn's disease	0.00129	0.00305	CcSEcCtD
Topotecan—Feeling abnormal—Mesalazine—Crohn's disease	0.00125	0.00297	CcSEcCtD
Topotecan—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00124	0.00295	CcSEcCtD
Topotecan—Neuropathy peripheral—Prednisone—Crohn's disease	0.00124	0.00293	CcSEcCtD
Topotecan—Hypersensitivity—Azathioprine—Crohn's disease	0.00123	0.00292	CcSEcCtD
Topotecan—Urticaria—Mesalazine—Crohn's disease	0.00121	0.00287	CcSEcCtD
Topotecan—Body temperature increased—Mesalazine—Crohn's disease	0.0012	0.00285	CcSEcCtD
Topotecan—Abdominal pain—Mesalazine—Crohn's disease	0.0012	0.00285	CcSEcCtD
Topotecan—Diarrhoea—Azathioprine—Crohn's disease	0.00114	0.00271	CcSEcCtD
Topotecan—Haemoglobin—Prednisone—Crohn's disease	0.00114	0.0027	CcSEcCtD
Topotecan—Haemorrhage—Prednisone—Crohn's disease	0.00113	0.00269	CcSEcCtD
Topotecan—Hypersensitivity—Mesalazine—Crohn's disease	0.00112	0.00266	CcSEcCtD
Topotecan—Dizziness—Azathioprine—Crohn's disease	0.0011	0.00262	CcSEcCtD
Topotecan—Asthenia—Mesalazine—Crohn's disease	0.00109	0.00259	CcSEcCtD
Topotecan—Pruritus—Mesalazine—Crohn's disease	0.00107	0.00255	CcSEcCtD
Topotecan—Vomiting—Azathioprine—Crohn's disease	0.00106	0.00252	CcSEcCtD
Topotecan—Rash—Azathioprine—Crohn's disease	0.00105	0.0025	CcSEcCtD
Topotecan—Dermatitis—Azathioprine—Crohn's disease	0.00105	0.00249	CcSEcCtD
Topotecan—Headache—Azathioprine—Crohn's disease	0.00104	0.00248	CcSEcCtD
Topotecan—Diarrhoea—Mesalazine—Crohn's disease	0.00104	0.00247	CcSEcCtD
Topotecan—Angiopathy—Prednisone—Crohn's disease	0.00103	0.00244	CcSEcCtD
Topotecan—Immune system disorder—Prednisone—Crohn's disease	0.00102	0.00243	CcSEcCtD
Topotecan—Dizziness—Mesalazine—Crohn's disease	0.001	0.00238	CcSEcCtD
Topotecan—Alopecia—Prednisone—Crohn's disease	0.001	0.00237	CcSEcCtD
Topotecan—Nausea—Azathioprine—Crohn's disease	0.000991	0.00235	CcSEcCtD
Topotecan—Malnutrition—Prednisone—Crohn's disease	0.000985	0.00234	CcSEcCtD
Topotecan—Vomiting—Mesalazine—Crohn's disease	0.000966	0.00229	CcSEcCtD
Topotecan—Rash—Mesalazine—Crohn's disease	0.000958	0.00227	CcSEcCtD
Topotecan—Dermatitis—Mesalazine—Crohn's disease	0.000957	0.00227	CcSEcCtD
Topotecan—Headache—Mesalazine—Crohn's disease	0.000952	0.00226	CcSEcCtD
Topotecan—Ill-defined disorder—Prednisone—Crohn's disease	0.000914	0.00217	CcSEcCtD
Topotecan—Anaemia—Prednisone—Crohn's disease	0.00091	0.00216	CcSEcCtD
Topotecan—Nausea—Mesalazine—Crohn's disease	0.000903	0.00214	CcSEcCtD
Topotecan—Angioedema—Prednisone—Crohn's disease	0.0009	0.00214	CcSEcCtD
Topotecan—Malaise—Prednisone—Crohn's disease	0.000888	0.00211	CcSEcCtD
Topotecan—Arthralgia—Prednisone—Crohn's disease	0.000839	0.00199	CcSEcCtD
Topotecan—Myalgia—Prednisone—Crohn's disease	0.000839	0.00199	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000833	0.00198	CcSEcCtD
Topotecan—Discomfort—Prednisone—Crohn's disease	0.000829	0.00197	CcSEcCtD
Topotecan—Anaphylactic shock—Prednisone—Crohn's disease	0.000804	0.00191	CcSEcCtD
Topotecan—Infection—Prednisone—Crohn's disease	0.000799	0.0019	CcSEcCtD
Topotecan—Nervous system disorder—Prednisone—Crohn's disease	0.000788	0.00187	CcSEcCtD
Topotecan—Skin disorder—Prednisone—Crohn's disease	0.000781	0.00185	CcSEcCtD
Topotecan—Hyperhidrosis—Prednisone—Crohn's disease	0.000777	0.00184	CcSEcCtD
Topotecan—Anorexia—Prednisone—Crohn's disease	0.000766	0.00182	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000732	0.00174	CcSEcCtD
Topotecan—Paraesthesia—Prednisone—Crohn's disease	0.000722	0.00171	CcSEcCtD
Topotecan—Dyspepsia—Prednisone—Crohn's disease	0.000708	0.00168	CcSEcCtD
Topotecan—Decreased appetite—Prednisone—Crohn's disease	0.000699	0.00166	CcSEcCtD
Topotecan—Fatigue—Prednisone—Crohn's disease	0.000693	0.00165	CcSEcCtD
Topotecan—Constipation—Prednisone—Crohn's disease	0.000687	0.00163	CcSEcCtD
Topotecan—Feeling abnormal—Prednisone—Crohn's disease	0.000662	0.00157	CcSEcCtD
Topotecan—Gastrointestinal pain—Prednisone—Crohn's disease	0.000657	0.00156	CcSEcCtD
Topotecan—Urticaria—Prednisone—Crohn's disease	0.000639	0.00152	CcSEcCtD
Topotecan—Body temperature increased—Prednisone—Crohn's disease	0.000635	0.00151	CcSEcCtD
Topotecan—Abdominal pain—Prednisone—Crohn's disease	0.000635	0.00151	CcSEcCtD
Topotecan—Hypersensitivity—Prednisone—Crohn's disease	0.000592	0.00141	CcSEcCtD
Topotecan—Asthenia—Prednisone—Crohn's disease	0.000577	0.00137	CcSEcCtD
Topotecan—Pruritus—Prednisone—Crohn's disease	0.000569	0.00135	CcSEcCtD
Topotecan—Diarrhoea—Prednisone—Crohn's disease	0.00055	0.00131	CcSEcCtD
Topotecan—Dizziness—Prednisone—Crohn's disease	0.000532	0.00126	CcSEcCtD
Topotecan—Vomiting—Prednisone—Crohn's disease	0.000511	0.00121	CcSEcCtD
Topotecan—Rash—Prednisone—Crohn's disease	0.000507	0.0012	CcSEcCtD
Topotecan—Dermatitis—Prednisone—Crohn's disease	0.000506	0.0012	CcSEcCtD
Topotecan—Headache—Prednisone—Crohn's disease	0.000504	0.0012	CcSEcCtD
Topotecan—Nausea—Prednisone—Crohn's disease	0.000478	0.00113	CcSEcCtD
